No definition available.
Osteochondrodysplasia with defects of growth of tubular bones and spine
Q17_OSTEOCHONDROD_W_DEFECTS_GROWTH_TUBULAR_BONES_SPINE
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
71 |
4. Check minimum number of eventsNone |
71 |
5. Include endpointsNone |
71 |
6. Filter based on genotype QC (FinnGen only) |
71 |
Control definitions (FinnGen only)
- Control exclude
- Q17_CONGEN_MALFO_DEFORMAT_MUSCULOS_SYSTEM
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- Q6[5-9]|Q7
- Name in latin
- Osteochondrodysplasia cum dysplasia ossium tubularium (longorum) et columnae vertebralis
Similar endpoints
↥List of similar endpoints to
Osteochondrodysplasia with defects of growth of tubular bones and spine
based on the number of shared cases.
Similar with more cases:
- Congenital malformations and deformations of the musculoskeletal system
- Congenital malformations, deformations and chromosomal abnormalities
- Any operation in hilmo
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 792 | 463 | 328 |
| Only index persons | 647 | 381 | 266 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.01 | 0.01 | 0.01 |
| Only index persons | 0.01 | 0.01 | 0.01 |
| Median age at first event (years) | |||
| Whole population | 13.08 | 14.89 | 10.36 |
| Only index persons | 18.07 | 21.85 | 12.66 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 71 | 48 | 23 |
| Unadjusted period prevalence (%) | 0.01 | 0.02 | 0.01 |
| Median age at first event (years) | 29.61 | 33.81 | 20.86 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 68
- Matched controls
- 681
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
Q77.9
ICD-10 Finland
Osteochondrodysplasia with defects of growth of tubular bones and spine, unspecified
+∞
20.9
19
*
Q77.82
ICD-10 Finland
Hair-cartilage hypoplasia
+∞
16.3
15
*
Z31.5
ICD-10 Finland
Genetic counselling
14.8
15.0
26
27
Q77.88
ICD-10 Finland
Other osteochondrodysplasia with defects of growth of tubular bones and spine
+∞
14.0
13
*
Q77.5
ICD-10 Finland
Dystrophic dysplasia
+∞
12.9
12
*
Q77.4
ICD-10 Finland
Achondroplasia
+∞
12.9
12
*
75640
ICD-8 Finland
Other congenital anomalies of musculoskeletal system, Other anomalies of ribs and sternum
+∞
10.7
10
*
NA7EA
NOMESCO Finland
Scoliosis X-ray examination
102.2
8.6
9
*
7564A
ICD-9 Finland
Other congenital musculoskeletal anomalies, Chondrodystrophy
+∞
8.5
8
*
Q78.9
ICD-10 Finland
Osteochondrodysplasia, unspecified
+∞
8.5
8
*
Q77.7
ICD-10 Finland
Spondyloepiphyseal dysplasia
+∞
7.4
7
*
RK110
NOMESCO Finland
NA
44.6
6.9
8
*
NE1AA
NOMESCO Finland
Pelvis X-ray examination
11.8
6.9
12
12
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
10.1
6.4
12
14
NFB60
NOMESCO Finland
Demanding prosthetic replacement of hip
+∞
6.3
6
*
M16.6
ICD-10 Finland
Other secondary coxarthrosis, bilateral
+∞
6.3
6
*
Q77.6
ICD-10 Finland
Chondroectodermal dysplasia
+∞
6.3
6
*
Q77.2
ICD-10 Finland
Short rib syndrome
+∞
6.3
6
*
M48.0
ICD-10 Finland
Spinal stenosis
14.4
6.3
10
8
NF1AA
NOMESCO Finland
Hip X-ray examination
11.7
6.3
11
11
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
14
11
15.61
14.69
2.4
4.9
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
21
65
4.17
6.34
7.6
8.1
mmol/l
1.2
1.3
0.72
21
59
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
43
222
3.38
5.89
3.7
2.7
nmol/l
81.5
76.3
0.43
43
206
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
43
240
3.01
4.85
10.1
6.5
mmol/l
1.2
1.2
0.38
38
214
(4062490)
8
9
9.83
4.40
1.3
1.2
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
38
208
2.78
4.30
10.9
8.9
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
23
101
2.89
3.88
6.6
4.6
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
6
5
12.92
3.83
5.8
2.6
u/ml
551.3
349.8
—
6
5
(3032080) INR in Blood by Coagulation assay
31
162
2.62
3.73
7.7
8.8
inr
1.3
1.2
—
10
46
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
38
228
2.43
3.33
10.3
7.8
mmol/l
1.2
1.2
0.05
38
217
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
9
21
4.75
3.11
1.3
1.8
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
9
21
4.75
3.11
1.3
1.8
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
17
71
2.83
3.09
1.8
1.3
—
—
—
0
0
(40758558) Short blood count panel - Blood
30
167
2.38
3.05
17.0
9.1
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
8
18
4.86
2.89
3.0
1.1
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
38
242
2.23
2.75
3.9
4.0
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
33
202
2.18
2.60
5.9
5.5
g/l
37.2
37.0
0.07
33
194
(3042111) Morphology [Interpretation] in Bone marrow Narrative
5
7
7.57
2.59
2.8
3.4
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
50
362
2.29
2.57
16.2
11.7
e9/l
4.1
3.8
0.28
44
319
(3013115) Eosinophils [#/volume] in Blood
46
325
2.18
2.48
11.8
9.1
e9/l
0.2
0.2
0.13
40
298
(3006315) Basophils [#/volume] in Blood
45
318
2.13
2.39
9.7
8.3
e9/l
0.0
0.0
0.02
39
282
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
11
42
2.92
2.31
2.4
1.3
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
11
42
2.92
2.31
2.3
1.5
—
—
—
0
0
(3012544) pH of Venous blood
15
68
2.53
2.30
3.3
9.6
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
5
9
5.88
2.25
2.0
2.0
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
5
9
5.88
2.25
1.4
2.8
—
—
—
0
0
(3000991) Gas panel - Venous blood
14
63
2.52
2.18
6.1
10.4
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
44
317
2.02
2.12
10.0
8.3
e9/l
0.5
0.5
0.24
39
281
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
7
20
3.76
2.11
16.4
15.3
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
8
26
3.33
2.08
1.1
1.6
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
6
15
4.26
2.08
3.8
2.1
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
30
192
1.97
1.99
3.6
3.2
e6/l
19.9
40.4
0.44
23
138
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
20
110
2.14
1.99
2.6
2.5
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
6
16
3.99
1.98
4.7
1.4
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
5
11
4.80
1.97
2.0
1.9
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
5
11
4.80
1.97
1.4
1.4
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
26
159
2.00
1.96
3.1
3.2
mmol/l
2.4
2.4
0.22
26
146
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
7
22
3.41
1.93
6.1
14.1
%
0.4
0.8
—
7
22
(3018418) pH of Serum or Plasma
23
136
2.02
1.89
7.4
3.2
ph
7.4
7.4
—
5
23
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
5
12
4.39
1.85
2.8
1.5
mg/l
8.7
7.9
—
5
12
(3025130) Human papilloma virus identified in Specimen
5
12
4.39
1.85
1.0
1.8
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
41
297
1.90
1.85
13.5
9.6
e9/l
0.0
0.0
0.71
36
238
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
7
23
3.26
1.85
6.1
13.6
%
0.9
1.9
—
7
23
(36304419) Bacteria [Presence] in Urine
25
154
1.96
1.83
3.5
2.4
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
26
164
1.92
1.77
3.5
1.7
g/l
1.7
2.6
1.30
21
88
(3052851) Hemolysis interference index of Serum or Plasma
5
13
4.05
1.74
3.2
2.9
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
12
57
2.33
1.66
3.9
2.0
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
23
142
1.92
1.65
3.3
2.5
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
0
45
0.00
1.56
0.0
1.3
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
15
81
2.08
1.54
3.3
2.5
e6/l
5.3
3.2
—
9
48
(3014007) Fractional oxyhemoglobin in Arterial blood
6
21
3.02
1.54
7.0
14.9
%
93.7
94.2
—
6
21
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
28
189
1.80
1.51
3.3
2.9
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
48
382
1.79
1.45
4.2
3.6
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
12
61
2.16
1.43
2.3
1.6
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
6
23
2.75
1.40
1.3
5.4
%
63.8
57.5
—
6
23
(3019060) Gas panel - Arterial blood
6
23
2.75
1.40
13.2
4.2
—
—
—
0
0
(40761535) Cells panel - Urine sediment
0
38
0.00
1.39
0.0
4.5
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
24
159
1.77
1.36
5.3
2.4
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
10
182
0.48
1.35
1.6
1.7
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
6
128
0.42
1.33
3.2
2.4
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
36
269
1.69
1.32
2.8
3.3
estimate
0.0
0.0
—
6
47
(3023520) Reticulocytes [#/volume] in Blood
8
35
2.45
1.32
3.0
5.7
e9/l
76.0
71.0
—
8
30
(3019550) Sodium [Moles/volume] in Serum or Plasma
64
570
2.24
1.26
19.4
12.1
mmol/l
138.6
139.6
2.36
64
558
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
23
157
1.69
1.16
1.8
1.7
pmol/l
94.2
100.2
—
10
87
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
15
91
1.82
1.11
2.9
3.2
ng/l
7.9
344.1
—
8
48
(3002256) Pathology report gross observation
11
60
1.99
1.10
1.4
1.1
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
15
92
1.80
1.08
3.3
2.4
e6/l
0.3
0.7
—
9
60
(3048929) Epstein Barr virus Ab [Presence] in Serum
9
47
2.05
1.07
1.1
1.6
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
35
271
1.57
1.05
3.8
4.3
estimate
0.0
0.0
—
9
47
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
0
29
0.00
1.00
0.0
1.6
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
35
274
1.55
0.99
2.9
3.3
estimate
0.0
0.0
—
9
43
(3003327) Ova and parasites identified in Stool by Light microscopy
6
27
2.33
0.96
1.2
1.6
—
—
—
0
0
(1002224) Polysomnography panel
6
27
2.33
0.96
1.0
1.1
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
6
114
0.48
0.93
3.2
2.3
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
11
64
1.85
0.92
1.6
2.9
mmol/l
2.5
2.4
0.39
11
56
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
22
157
1.58
0.91
2.0
3.7
ng/l
8.6
16.8
—
8
85
(3044889) 12 lead EKG panel
44
368
1.51
0.88
2.7
2.7
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
8
45
1.87
0.88
8.5
11.8
mmol/l
25.4
25.5
—
8
45
(3004119) Hemoglobin [Mass/volume] in Venous blood
6
32
1.95
0.84
1.2
10.0
g/l
129.5
129.6
—
6
32
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
6
33
1.89
0.81
2.5
1.7
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
0
24
0.00
0.81
0.0
1.5
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
0
26
0.00
0.80
0.0
1.5
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
0
26
0.00
0.80
0.0
1.5
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
0
26
0.00
0.80
0.0
1.5
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
0
26
0.00
0.80
0.0
1.5
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
40
333
1.46
0.79
9.1
5.9
mmol/l
5.8
6.3
1.14
40
307
(3022145) Colonoscopy Study observation
9
55
1.73
0.77
1.3
1.5
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
5
25
2.07
0.74
2.6
1.6
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
11
69
1.70
0.73
2.8
2.2
umol/l
14.1
15.2
0.13
11
63
(40768797) Stomach Pathology biopsy report
10
61
1.74
0.73
1.1
1.4
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
5
26
1.99
0.72
1.2
6.6
mmol/l
26.0
23.7
—
5
26
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
5
26
1.99
0.72
1.0
1.1
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
7
43
1.70
0.69
8.4
12.2
mmol/l
7.6
5.4
—
7
43
(1761868) Lipid panel - Serum or Plasma
16
216
0.67
0.68
3.0
2.4
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
7
44
1.65
0.67
1.1
1.2
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
5
30
1.72
0.62
1.8
17.3
mg/l
0.8
1.1
—
5
30
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
0
21
0.00
0.61
0.0
1.5
—
—
—
0
0
(3022621) pH of Urine by Test strip
6
34
1.83
0.60
3.5
1.6
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
0
23
0.00
0.59
0.0
1.4
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
0
23
0.00
0.59
0.0
1.4
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
6
38
1.63
0.56
1.7
1.3
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
46
509
0.73
0.56
3.4
3.6
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
21
164
1.40
0.55
2.4
2.2
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
7
110
0.60
0.53
1.1
1.7
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
63
594
1.54
0.51
20.1
11.5
mg/l
16.8
21.4
1.00
50
435
(40760892) CBC W Ordered Manual Differential panel - Blood
18
140
1.38
0.48
5.5
5.6
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
11
150
0.68
0.48
1.5
1.7
mmol/l
1.4
1.3
0.10
11
134
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
0
15
0.00
0.41
0.0
2.3
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
0
17
0.00
0.41
0.0
1.3
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
0
17
0.00
0.41
0.0
1.3
—
—
—
0
0
(40768443) Skin Pathology biopsy report
0
17
0.00
0.41
0.0
1.1
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
0
18
0.00
0.40
0.0
1.5
—
4.0
—
0
6
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
5
35
1.46
0.40
2.2
3.9
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
0
19
0.00
0.39
0.0
1.5
—
1.6
—
0
5
(3011288) Drugs identified in Urine by Screen method
5
36
1.42
0.39
1.2
1.8
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
25
212
1.28
0.37
1.9
1.7
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
6
41
1.51
0.37
6.0
4.0
mmol/l
24.2
24.8
—
6
41
(4035726)
6
42
1.47
0.36
2.3
1.5
—
—
—
0
0
(3022313) Gas panel - Capillary blood
6
43
1.43
0.36
6.7
4.1
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
6
44
1.40
0.35
1.7
1.4
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
6
48
1.27
0.21
1.7
1.3
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
6
48
1.27
0.21
1.7
1.3
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
6
49
1.24
0.20
1.7
1.3
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
6
49
1.24
0.20
1.7
1.3
—
—
—
0
0
(4306422)
0
14
0.00
0.20
0.0
1.2
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
0
14
0.00
0.20
0.0
1.4
—
220.1
—
0
14
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
6
51
1.19
0.20
1.2
1.8
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
5
67
0.73
0.18
5.0
3.7
ug/l
2.0
1.3
—
5
59
(3009542) Hematocrit [Volume Fraction] of Blood
60
582
1.20
0.15
23.3
13.0
%
39.6
40.4
0.55
49
494
(46235355) HIV 1 and 2 tests - Meaningful Use set
15
168
0.86
0.13
2.0
2.2
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
24
221
1.13
0.13
2.3
3.2
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
15
134
1.15
0.12
1.9
1.4
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
5
44
1.15
0.10
2.0
2.3
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
11
98
1.14
0.08
1.5
1.7
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
6
72
0.82
0.08
1.3
1.9
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
8
73
1.11
0.08
3.1
6.6
s
28.6
30.9
—
8
73
(3019832) Treponema pallidum Ab [Presence] in Serum
9
99
0.90
0.07
1.4
1.9
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
51
500
1.07
0.04
19.3
9.1
ml/min/173m2
105.7
92.1
3.43
42
389
(3020682) Albumin/Creatinine [Ratio] in Urine
12
112
1.09
0.03
3.0
3.7
mg/mmol
4.2
14.7
—
7
67
(3029937) Albumin [Presence] in Urine by Test strip
16
152
1.07
0.02
2.8
3.8
estimate
0.0
0.0
—
8
48
(3015736) pH of Urine
22
213
1.05
0.01
2.0
3.3
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
13
124
1.06
0.01
2.8
3.9
—
—
—
0
0
(3013512) EKG study
11
113
0.97
0.00
3.0
2.7
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
14
135
1.05
0.00
1.4
1.8
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
18
176
1.03
0.00
2.0
1.6
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
5
57
0.87
0.00
2.4
1.3
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(3028271) Lactate [Moles/volume] in Capillary blood
0
8
0.00
0.00
0.0
1.8
—
1.6
—
0
8
(4094501)
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
0
9
0.00
0.00
0.0
2.3
—
29.5
—
0
9
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
0
5
0.00
0.00
0.0
2.2
—
14.6
—
0
5
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
8
82
0.97
0.00
1.1
1.2
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(4027681)
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
5.4
—
0
5
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
0
5
0.00
0.00
0.0
6.6
—
—
—
0
0
(3020717) Zinc [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.4
—
13.7
—
0
5
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
0
5
0.00
0.00
0.0
6.6
—
—
—
0
0
(3000492) Spirometry study
6
66
0.90
0.00
2.3
1.3
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
0
7
0.00
0.00
0.0
1.4
—
92.4
—
0
7
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
8.3
—
655.0
—
0
6
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
19.3
—
1041.3
—
0
6
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
12.0
—
7.8
—
0
5
(3035933) Granulocytes/100 leukocytes in Blood
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint Q17_OSTEOCHONDROD_W_DEFECTS_GROWTH_TUBULAR_BONES_SPINE and mortality.
Females
No dataMales
No dataMortality risk
Mortality risk for people of age
years, who have Q17_OSTEOCHONDROD_W_DEFECTS_GROWTH_TUBULAR_BONES_SPINE.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | No data |
| 5 | No data | No data |
| 10 | No data | No data |
| 15 | No data | No data |
| 20 | No data | No data |
Relationships between endpoints
↥Index endpoint: Q17_OSTEOCHONDROD_W_DEFECTS_GROWTH_TUBULAR_BONES_SPINE – Osteochondrodysplasia with defects of growth of tubular bones and spine
GWS hits: 2
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data